Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Ebos meets guidance as 1H profit more than triples

Ebos meets guidance as 1H profit more than triples, to overhaul executive team

Feb. 19 (BusinessDesk) – Ebos Group said first-half profit more than tripled, meeting its guidance after the acquisition of Symbion, and said its top executives would be replaced by managers of the Australian drug distributor and distributor.

Profit was $49.9 million in the six months ended Dec. 31, up from about $15 million a year earlier, the Christchurch-based company said in a statement. Sales jumped to $3 billion from $755 million. Ebos forecast a profit of $48.7 million on sales of $3.17 billion at its annual meeting in October.

The $1.1 billion cash and scrip Symbion purchase was a game-changer for Ebos, more than tripling annual revenue in a deal that gave Symbion’s owner Zuellig Group a cornerstone 40 percent stake in the New Zealand business and adding to the Hong Kong-based group’s 30 stake in chemist chain PharmacyBrands.

The results announcement marks a changing of the guard at the company that has grown through acquisitions to include medical products distribution, pet products and now pharmaceuticals with 19 acquisitions in 12 years. The shares rose 3.1 percent to $10 and have gained 156 percent in the past five years, almost twice the gains of the NZX 50 Index. It also listed on the ASX in the latest year.

Chairman Rick Christie will retire at the company’s annual meeting in October after 10 years in the role and will be replaced by chief executive Mark Waller.

In turn, Waller will be replaced as CEO by Patrick Davies, who had been CEO of Symbion and chief financial officer Dennis Doherty, who held off retiring pending the Symbion purchase, will be replaced by Symbion CFO John Cullity.

Christie called the changes “the right mix of continuity to maintain our strategic director, proven operational talent and a seamless transition, with an even stronger growth focus.”

Ebos will pay a first-half dividend of 20.5 cents a share on April 4, with a record date of March 14. That’s up from 17.5 cents a year earlier.

The company operates as two main divisions, healthcare and animal care. In the first half, revenue from healthcare soared to $2.8 billion from $673 million a year earlier, reflecting revenue from Symbion, while profit climbed to $52.2 million from $12.8 million.

Animal care, made up of the Procter & Gamble pet care, Eukanuba and IAMS pet food, and the Vitapet grocery brands acquired with the 2011 acquisition of Masterpet Group for $105 million plus debt, lifted sales to $177 million from $81 million and profit gained to $9.5 million from $6.4 million.

Gearing was a relatively mild 26.7 percent and Ebos said it has $390 million in undrawn bank facilities, giving it “significant headroom for future growth.”

The company said it assessed “a number of acquisition opportunities” in the first half though none met its shareholder returns criteria.

With the addition of Symbion, Ebos got A$2.09 billion of its revenue across the Tasman, while New Zealand sales accounted for $649.6 million. Profit from Australia was A$41.7 million and from New Zealand was $14.8 million.

That means the strength of the kiwi dollar against the Australian dollar is a major component of its results. The kiwi was recently at 91.95 Australian cents from 81.44 cents a year ago.

The currency “remains on our radar,” Ebos said in presentation slides today. It gave no specific guidance for the full year while noting that the trading mix has traditionally been skewed 52 percent-48 percent between the first and second halves.

(BusinessDesk)

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Scoop Business: RBNZ Keeps OCR At 3.5%, Signals Slower Pace Of Future Hikes

Reserve Bank governor Graeme Wheeler kept the official cash rate at 3.5 percent and signalled he won’t be as aggressive with future rate hikes as previously thought as inflation remains tamer than expected. The kiwi dollar fell to a seven-month low. More>>

ALSO:

Weather: Dry Spells Take Hold In South Island

Many areas in the South Island are tracking towards record dry spells as relatively warm, dry weather that began in mid-August continues... for some South Island places, the current period of fine weather is quite rare. More>>

ALSO:

Scoop Business: Productivity Commission To Look At Housing Land Supply

The Productivity Commission is to expand on its housing affordability report with an investigation into improving land supply and development capacity, particularly in areas with strong population growth. More>>

ALSO:

Forestry: Man Charged After 2013 Death

Levin Police have arrested and charged a man with manslaughter in relation to the death of Lincoln Kidd who was killed during a tree felling operation on 19 December 2013. More>>

ALSO:

Smells Like Justice: Dairy Company Fined Over Odour

Dairy company fined over odour Dairy supply company Open Country Dairy Limited has been convicted and fined more than $35,000 for discharging objectionable odour from its Waharoa factory at the time of last year’s ”spring flush” when milk supply was high. More>>

Scoop Business: Dairy Product Prices Decline To Lowest Since July 2012

Dairy product prices dropped to the lowest level since July 2012 in the latest GlobalDairyTrade auction, led by a slump in rennet casein and butter milk powder. More>>

ALSO:

SOE Results: TVNZ Lifts Annual Profit 25% On Flat Ad Revenue, Quits Igloo

Television New Zealand, the state-owned broadcaster, lifted annual profit 25 percent, ahead of forecast and despite a dip in advertising revenue, while quitting its stake in the pay-TV Igloo joint venture with Sky Network Television. More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news